BPC-157 and NAD+

BPC-157 + Nicotinamide Adenine Dinucleotide Protocol

AI explanation

BPC-157 and NAD+

Think of your gut like a house with damaged walls and a failing electrical system. BPC-157 is the repair crew that rebuilds those walls—it specifically targets your intestinal lining, stimulating new blood vessel growth and telling your body to strengthen the barrier that keeps harmful things out. It also calms down the inflammatory noise your immune system is making in that area. NAD+ is different; it's like upgrading your electrical grid. It's a fuel molecule your cells desperately need to produce energy and fix their own DNA damage.

Together, they work at two levels. BPC-157 initiates the actual structural healing of your gut tissue, while NAD+ gives your cells the energy currency they need to actually complete that repair work efficiently. Without enough NAD+, your cells are trying to rebuild with limited power. With both running, you're essentially telling your body "here's the blueprint for healing, and here's the fuel to do it properly."

This combination has become popular for people dealing with gut issues, inflammatory conditions, or anyone trying to support their body's natural repair processes. The idea is that you're not just patching the damage—you're restoring the cellular machinery that makes healing actually possible.

Dosage Information

Typical Dose

BPC-157: 250-500 mcg + NAD+: 250-500 mg

Frequency

BPC-157 once or twice daily. NAD+ once daily in the morning.

Morning or evening

Administration

BPC-157 subcutaneous injection. NAD+ oral capsule or IV infusion.

Half-Life

4–6 hours

estimated

Notes

BPC-157 oral form (arginate) can be used for gastrointestinal applications. IV NAD+ provides faster cellular uptake but oral NMN or NR are more practical for daily use as NAD+ precursors.

Why this matters

Stack follows BPC-157 half-life; NAD+ component has independent kinetics.

Protocol cycle

as needed· No cycling protocol specified in dosage data

Dose Calculator

Calculate your draw amount for an insulin syringe (U-100)

Concentration: 2,500 mcg/mL

This dose requires more than one full syringe. Consider using a larger water volume to reduce concentration, or splitting into multiple injections.

Sign in to save your reconstitution settings for this peptide

Draw to the

6280

unit mark

020406080100

Draw 6280 units for your 157000mcg dose of BPC-157 and NAD+

This calculator is for educational purposes. Always verify your calculations and consult a healthcare professional.

Where does BPC-157 and NAD+ sit?

See how this peptide compares across all 150 peptides in our database.

Evidence Score

0.07

Clinical trials
0.0035%
Literature
0.0030%
Community
0.0020%
Completeness
0.5015%

Potential Side Effects

BPC-157: mild nausea (uncommon), injection site reactions (uncommon)NAD+/NMN: mild nausea at high doses (uncommon), flushing (uncommon)
Pep Talk

BPC-157 and NAD+ discussions

Quick Facts

Administration
BPC-157 subcutaneous injection. NAD+ oral capsule or IV infusion.
Typical Dose
BPC-157: 250-500 mcg + NAD+: 250-500 mg
Frequency
BPC-157 once or twice daily. NAD+ once daily in the morning.
References
0 curated + 0 from PubMed
Evidence Score
0.1 / 100

Frequently Asked Questions about BPC-157 and NAD+

What is BPC-157 and NAD+?

The BPC-157 and NAD+ combination has emerged as one of the most discussed gut health and systemic repair protocols in the peptide research community. BPC-157 provides targeted gastrointestinal healing and tissue repair while NAD+ supports cellular energy production and DNA repair through sirtuin activation. Together they address both the structural repair of damaged tissue and the cellular energy infrastructure required for optimal healing. This combination is particularly popular for gut health recovery inflammatory bowel conditions and systemic anti-aging protocols.

How does BPC-157 and NAD+ work?

BPC-157 promotes gastric mucosal healing through upregulation of growth hormone receptors and VEGF-driven angiogenesis stabilizing the nitric oxide system and reducing inflammatory cytokine production in gastrointestinal tissue. NAD+ replenishes cellular coenzyme levels supporting mitochondrial energy production PARP-mediated DNA repair and sirtuin deacetylase activity. The combination addresses healing at two levels — BPC-157 repairs the structural tissue damage while NAD+ restores the cellular metabolic capacity required for efficient repair. NAD+ supplementation also supports the energy-intensive process of tissue regeneration that BPC-157 initiates making the combination theoretically synergistic for recovery applications.

What is the recommended dosage for BPC-157 and NAD+?

The typical dose is BPC-157: 250-500 mcg + NAD+: 250-500 mg. BPC-157 once or twice daily. NAD+ once daily in the morning.. Administration: BPC-157 subcutaneous injection. NAD+ oral capsule or IV infusion.. BPC-157 oral form (arginate) can be used for gastrointestinal applications. IV NAD+ provides faster cellular uptake but oral NMN or NR are more practical for daily use as NAD+ precursors.

What are the side effects of BPC-157 and NAD+?

BPC-157: mild nausea (uncommon), injection site reactions (uncommon). NAD+/NMN: mild nausea at high doses (uncommon), flushing (uncommon)

What is the BPC-157 and NAD+ cycle protocol?

BPC-157 and NAD+ is typically cycled as needed. No cycling protocol specified in dosage data

Questions reflect common community inquiries. This is not medical advice.